- Previous Close
952.50 - Open
952.50 - Bid 930.00 x --
- Ask 933.00 x --
- Day's Range
925.00 - 952.50 - 52 Week Range
249.40 - 1,570.00 - Volume
16,887 - Avg. Volume
116,571 - Market Cap (intraday)
277.253M - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
-- - EPS (TTM)
-0.74 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
www.epitomeemedical.comRecent News: EPIT.TA
View MorePerformance Overview: EPIT.TA
Trailing total returns as of 1/19/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EPIT.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EPIT.TA
View MoreValuation Measures
Market Cap
283.96M
Enterprise Value
194.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.81
Price/Book (mrq)
2.63
Enterprise Value/Revenue
5.38
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-60.35%
Return on Assets (ttm)
1.07%
Return on Equity (ttm)
-18.64%
Revenue (ttm)
10M
Net Income Avi to Common (ttm)
-6.04M
Diluted EPS (ttm)
-0.74
Balance Sheet and Cash Flow
Total Cash (mrq)
29.14M
Total Debt/Equity (mrq)
14.17%
Levered Free Cash Flow (ttm)
-1.48M